Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
GEO DataSets Profile neighbors
HES6 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PDCL3P4 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
CLC - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
CD320 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
USP30 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
LINC00938 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
GEO DataSets Gene Profile neighbors Chromosome neighbors
DRD1 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
SMARCA2 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
PEX10 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
TBC1D15 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
HILPDA - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
NANOS1 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
IGLJ3 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
SERINC1 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
RALGAPB - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
PRKAR1A - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
SAP30 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
MFGE8 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on